Shares of Colfax Corp (NYSE:CFX) have been assigned a consensus recommendation of “Hold” from the twenty-one ratings firms that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have given a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $28.59.
A number of analysts have commented on the stock. Barclays lifted their target price on shares of Colfax from $31.00 to $33.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 7th. Citigroup lifted their target price on shares of Colfax from $18.00 to $21.00 and gave the stock a “sell” rating in a report on Friday, May 8th. Deutsche Bank boosted their price target on shares of Colfax from $19.00 to $30.00 and gave the company a “hold” rating in a report on Friday, May 8th. Zacks Investment Research lowered shares of Colfax from a “hold” rating to a “sell” rating and set a $26.00 price target for the company. in a report on Tuesday, April 28th. Finally, Morgan Stanley boosted their price target on shares of Colfax from $23.00 to $28.00 and gave the company an “equal weight” rating in a report on Friday, May 8th.
CFX traded down $0.84 during trading on Tuesday, reaching $29.08. 1,281,053 shares of the company’s stock were exchanged, compared to its average volume of 781,107. The company’s fifty day moving average price is $28.84 and its 200-day moving average price is $28.63. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.25 and a current ratio of 1.93. Colfax has a fifty-two week low of $12.23 and a fifty-two week high of $39.30. The firm has a market capitalization of $3.44 billion, a PE ratio of -8.40, a P/E/G ratio of 4.81 and a beta of 1.84.
In other Colfax news, EVP Shyam Kambeyanda sold 14,829 shares of the business’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $22.97, for a total transaction of $340,622.13. Following the sale, the executive vice president now directly owns 57,212 shares of the company’s stock, valued at approximately $1,314,159.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Rajiv Vinnakota sold 1,800 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $27.44, for a total transaction of $49,392.00. Following the sale, the director now directly owns 21,888 shares in the company, valued at $600,606.72. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 42,829 shares of company stock valued at $1,180,358. Company insiders own 12.00% of the company’s stock.
A number of large investors have recently modified their holdings of CFX. Advisor Group Holdings Inc. bought a new stake in Colfax during the 1st quarter worth about $33,000. Synovus Financial Corp bought a new stake in Colfax during the 1st quarter worth about $55,000. Tower Research Capital LLC TRC bought a new stake in Colfax during the 1st quarter worth about $64,000. Cerebellum GP LLC bought a new stake in Colfax during the 2nd quarter worth about $82,000. Finally, Macquarie Group Ltd. bought a new stake in shares of Colfax in the 4th quarter valued at about $102,000. 99.94% of the stock is currently owned by hedge funds and other institutional investors.
Colfax Company Profile
Colfax Corporation operates as a diversified technology company worldwide. The company operates through Air and Gas Handling, and Fabrication Technology segments. The Air and Gas Handling segment designs, manufactures, installs, and maintains heavy-duty fans, rotary heat exchangers, blowers, and compressors.
Further Reading: How is a management fee different from a performance fee?
Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.